- Biotechnology
- Tuesday, 30 Mar 2021
DNA Next Generation Sequencing Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2018-2025
According to The Insight Partners market research study titled DNA Next Generation Sequencing Market - Global Analysis and Forecasts By Product, Application and End User, the global DNA next generation sequencing market is expected to reach US$ 22,716.9 Mn in 2025 from US$ 4,898.5 Mn in 2017. The market is estimated to grow with a CAGR of 21.7% from 2018-2025. The report highlights the trends prevalent in the global DNA next generation sequencing market and the factors driving the market along with those that act as deterrents to its growth.
Global DNA next generation sequencing market, based on the product was segmented as, platforms, services and consumables. In 2017, the consumables segment held the largest share of the market, by product. The segment is also expected to witness growth at a significant rate during the forecast period, as they are being used at numerous stages of DNA sequencing, which include sample generation, storing the samples and its purification, preparation of the library and quantification, and PCR amplification.
The market for DNA next generation sequencing is expected to grow significantly due to factors such as, declining price of sequencing, technological advancements in sequencing and increasing prevalence of cancer. In addition, usage of NSG in biomarker discovery & precision medicine is anticipated to have a positive impact on the growth of the DNA next generation sequencing market in the coming years.
Get PDF Sample Copy of this Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.theinsightpartners.com/sample/TIPRE00002934/
Some of the prominent players operating in DNA next generation sequencing market are, Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Beijing Genomics Institute, Perkinelmer, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Oxford Nanopore Technologies, and Macrogen, Inc. among others. The market players are focused towards introducing new and innovative products in the market to sustain their position in the market. For instance, in November, 2018, QIAGEN launched new bioinformatics analysis tool. The new tool incorporates the best of two previous QIAGEN products — CLC Biomedical Genomics Workbench and CLC Genomics Workbench. These product innovations and launches are expected to propel the growth of the DNA next generation sequencing market during the forecast period.
Next-generation sequencing (NGS), also known as high-throughput sequencing. NGS enables rapid sequencing of the base pairs in DNA samples. NGS is driving discovery and enabling the future of personalized medicine, genetic diseases, and clinical diagnostics. Key factors driving the growth of DNA next generation sequencing market are, increase in cancer prevalence, rise in funds and grants, focus of industry players and various meetings, conferences, workshops The report would be of an interest to various stakeholders operating in the DNA next generation sequencing market. These stakeholders include healthcare institutes, research institutes, infusion pumps product manufacturers and vendors, research consulting firms, service or product providers, distributors and others.
The objective of the study is to describe, define, and forecast the DNA next generation sequencing market by product, application, end user, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall DNA next generation sequencing market.
Purchase a copy of this research report @ https://www.theinsightpartners.com/buy/TIPRE00002934/
The report analyzes factors affecting market from both demand and supply side and further evaluates DNA next generation sequencing market dynamics effecting the DNA next generation sequencing market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies. Some of the prominent players operating in DNA next generation sequencing market globe include, Illumina, Inc., Thermo Fisher, Qiagen N.V., Beijing Genomics Institute, PerkinElmer, Inc., F.Hoffman-La Roche Ltd., Agilent Technologies, Eurofins Scientific, Oxford Nanopore Technologies Ltd. and Macrogen Inc.
The company players are indulged into development of novel and innovative products to cater the demands of users in the DNA next generation sequencing market. For instance, in December, 2018, Illumina, Inc. launched new high-density genotyping array, the Infinium Global Diversity Array. This new array was developed through All of Us Research Program. The array allows the program to complete genotyping and sequencing for all 1 million or more people who participate in the program
Related Industry Updates
Biodegradable Stents Market Evolving Opportunities With Top Industry Experts
Apr 05, 2021
Feminine Hygiene Products Market with COVID-19 Impact and Recovery Analysis Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast 2027
Mar 27, 2021
AstronauTx announces an alliance with Concept Life Sciences to accelerate the identification of new therapies for Alzheimer's
Jun 02, 2020
Asia Pacific L-Carnitine Market Study Offering Deep Insight Related to Growth Trends Until 2027
Mar 31, 2021
Cell Expansion Market Global Business Growing Strategies, Technological Innovation And Emerging Trends Of Outlook To 2027
Jun 08, 2020
Analyzing Impacts Of COVID-19 On Smart Hospitals Market Effects, Aftermath And Forecast To 2027
Mar 31, 2021
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
Apr 27, 2020